The 50 most sponsor-active Biotechnology newsletters, ranked by our Newsletter Leader Score.
No properties or people on this page match your search. Try another name or clear the search.
Biotech and biopharma business-news briefings focused on science, people, financing, deals, regulation and drug development. The publication serves executives, investors and other senior life-sciences professionals.
A weekday biotech and pharma news newsletter covering clinical readouts, FDA decisions, gene therapy, drug pricing, financing, M&A and research partnerships. It is designed for pharmaceutical and biotechnology industry decision-makers.
A skimmable daily email covering the most important biotech and pharmaceutical news, including clinical trials, FDA decisions, financings, M&A and company launches. It is aimed at biotech and pharma professionals who want a concise industry…
A specialist biotech and life-sciences newsletter focused on AI in drug discovery, digital pathology, translational R&D, laboratory technology, and the intersection of software and biology. BiopharmaTrend markets newsletter sponsorships and…
Long-form reporting, essays, and podcasts on biotechnology, scientific progress, and the tools and ideas shaping biology. Its audience includes biotechnologists and readers interested in how biological science works and develops.
Delaware Bio’s newsletter covers biotechnology and the regional bioscience ecosystem, including company news, research, workforce, policy, and events.
A high-volume biotech trade publication covering clinical development, research, financing, M&A, regulatory policy, and company strategy. Its newsletter and broader Fierce Life Sciences network are heavily commercialized through sponsored c…
A weekly global biotech newsletter with a strong European focus, covering emerging companies, scientific technologies, funding rounds, industry trends, deals, and therapeutic areas. Labiotech reports a subscriber base of more than 20,000 ph…
A biology and life-sciences publication delivering interviews and reporting on genomics, genomic medicine, and related research. Its editions are sent to subscribers and its sponsorship materials report an audience of 18,500 subscribers.
A monthly newsletter for leaders of emerging biopharma firms, featuring biotech founder and operator conversations and editorial picks on funding, clinical development, manufacturing, regulation, and commercialization.
Weekday industry intelligence on biopharma, biotechnology, drug development, clinical results, deals, and regulation. Its readership includes professionals making and tracking life-sciences business and R&D decisions.
A weekday life-sciences intelligence newsletter covering biotech breakthroughs, clinical trials, FDA activity, financing, M&A, medtech, diagnostics, and healthcare innovation. The publication sells prominent above-the-fold newsletter sponso…
A recurring biotech community newsletter and email-briefing program featuring regional and global biotechnology news, jobs, events, and company updates across Biotech Networks hubs.
A short daily biotech briefing covering financings, IPOs, M&A, clinical trials, policy, and notable scientific developments. It is designed as a five-minute, high-signal update for biotech professionals.
Daily weekday newsletters covering biotech and life-science activity across eight major U.S. clusters, including financings, clinical milestones, partnerships, hires, events, and regional ecosystem news. The newsletters are marketed to biot…
BioBuzz publishes regional life sciences news roundups and offers newsletter advertising across its weekly editions. Coverage includes biotech industry news, company developments, workforce, funding, and events.
A weekly, informal biotech and life-science newsletter mixing industry news, company updates, jobs, directory developments, and humorous commentary for biotechnology professionals.
A weekly newsletter covering drug development, biologics, formulation, delivery technologies, and related industry news. Its readers include pharmaceutical and biotechnology R&D professionals and industry suppliers.
Weekly biotechnology coverage spanning scientific papers, funding rounds, emerging technologies, companies, and researchers. BioByte is the flagship newsletter of Decoding Bio, a community-oriented biotech media and events platform.
Weekly analysis of biotech and biopharma news, clinical-trial readouts, FDA decisions, M&A, public markets, and the science behind industry headlines.
A weekly LinkedIn-based newsletter covering AI in drug discovery, competitive dynamics, biotech platforms, therapeutic innovation, and technology-driven changes in life sciences.
A twice-weekly biotech and pharma briefing summarizing M&A, clinical breakthroughs, regulatory developments, funding, drug-discovery platforms, and industry strategy in a concise format. It targets scientists, founders, investors, operators…
A weekly global biotech newsletter with a focus on Asian biotech and East–West industry collaboration. It covers company deals, clinical developments, policy, and biotech investment.
A weekly publication about emerging technologies changing biotech, including synthetic biology, AI protein design, genome editing, and DNA nanotechnology. Its site says it is read by more than 700 people shaping biotech.
A weekly publication about how technology and process changes affect drug discovery and biotech. It covers topics including AI and software adoption, biotech data practices, and the operational challenges of scaling life-science research.
STAT's weekday biotech newsletter covering the science, politics, money, clinical readouts, FDA decisions, deals, and major company developments shaping biotechnology. Issues are written by STAT's biotech reporting team rather than one cons…
A targeted life-science research newsletter program covering genetics, genomics, molecular biology, cell biology, microbiology, CRISPR, gene therapy, proteomics, and related biotechnology fields. Sponsors can purchase topic-specific placeme…
An independent weekly bulletin covering the British biotech and venture-capital ecosystem, including funding, scientific breakthroughs, pharmaceutical strategy, senior appointments, and life-science infrastructure. The newsletter is aimed a…
A weekly bioprocessing newsletter covering biologics manufacturing, capacity expansion, M&A, technology investment, regulation, and global market developments.
A weekly biotech and biopharma intelligence edition covering drug development, deals, finance, policy, and company strategy. It serves industry executives, investors, and other life-sciences decision-makers.
A weekly life-sciences letter covering biomedical breakthroughs, drug development, and the people and manufacturing work behind medicines. It is produced by Katalyze AI and includes reporting for biotech and pharmaceutical professionals.
A weekly briefing on psychedelic medicines, drug development, clinical and regulatory news, business, and policy. It serves readers following the emerging psychedelic therapeutics sector.
An independent biotechnology research publication covering companies, therapeutic areas, capital markets, valuation, competition, and the forces shaping the biotech ecosystem. It serves investors, operators, scientists, physicians, and othe…
A regional briefing on technology, funding, and innovation across the BioHealth Capital Region, including biotechnology and biopharma companies, research, and startup activity.
Independent analysis of biopharma strategy, M&A, competitive positioning, clinical developments, and drug-market dynamics. Its audience is described as biopharma professionals with company budget responsibility.
A practical bioscience newsletter delivering quick-read laboratory protocols, troubleshooting guidance, technical explainers, career advice, and research tools to working scientists.
A topic-specific newsletter covering molecular biology, genomics, gene expression, CRISPR, and related life-science research. Biocompare offers text-based newsletter sponsorships with primary and secondary placements.
A briefing on AI and biology covering research, tools, deals, and biotech developments. Its issues reach founders, operators, scientists, and others following the AI-biology field.
BioPitch publishes long-form interviews with biotech founders, executives, and investors, focusing on the science, financing, partnerships, and decisions behind companies. It offers sponsored features and other partnerships to a global life…
Independent, subscription-supported biotech reporting and analysis covering drug development, diagnostics, genomics, regulatory issues, business strategy, and industry leaders. The publication explicitly operates without advertising and mon…
Biotech investing newsletter focused on clinical catalysts, regulatory events, drug-development strategy, portfolio tracking, and risk-adjusted analysis for public biotechnology companies.
Weekly, opinionated intelligence on how artificial intelligence is changing pharmaceutical research, biotech operations, drug discovery, scientific software, and regulated workflows.
A weekly biotech and pharma briefing that selects major global industry stories and explains them through Korean-market and career perspectives. It is aimed especially at students and early-career professionals preparing for biotech and pha…
A weekly biotech newsletter explaining scientific advances, industry developments, policy shifts, and biotech terminology. Written for readers who want an accessible, scientist-informed guide to the biotechnology industry.
Independent email newsletter analyzing clinical-stage biotech companies, trial data, catalysts, and investment theses. Written for readers following biotech stocks and drug-development outcomes.
Weekly coverage and market updates focused on stem cells, cell therapy, and regenerative medicine. Its readership includes industry professionals, investors, and scientists.
A weekly biotech publication covering clinical data, drug development, company acquisitions, and the science behind new therapies. Its readership includes people following biotech innovation and clinical research.
A biweekly life-sciences newsletter covering biotech investment, innovation, partnerships, and business strategy. It is marketed to biotechnology leaders, investors, and senior biopharma decision-makers.
A monthly briefing on emerging biotechnology, biomanufacturing, and related national-security policy. It covers Commission research, legislation, events, and developments across the U.S. biotech ecosystem.
A recurring life-science methods and biotechnology newsletter covering laboratory techniques, instrumentation, molecular biology, sequencing, imaging, and research tools. BioTechniques has documented newsletter advertising and sponsorship i…
These are real sponsors backing the communities on this list — discovered by Sponsor Scout's daily AI agent. Sign up free to see who's actively sponsoring right now, find the decision-makers, and reach out.
Property owners can submit evidence for Sponsor Scout review. Acceptance into Sponsor Scout does not guarantee placement in the public Top 25; rankings remain evidence-based and editorially independent.
Sign up to submit → Already have an account? Sign inEvery newsletter is scored 0–100 by Sponsor Scout as we search the open web daily. The score rewards newsletters that reach real audiences and consistently attract sponsors. These findings are updated regularly.
Sponsor Scout hunts the web every day for companies sponsoring startup & tech events, finds the right decision-maker, and drafts the outreach for you. Start free — 20 sponsors and 4 scout runs every month, no credit card.
One short email each weekday: a real story about a real company sponsoring the startup ecosystem, plus the day's freshest finds.